Clinical Applications

This product contains a combination of Cefalexin and Trimethoprim, formulated for the effective treatment of bacterial infections. Cefalexin acts as a cephalosporin antibiotic, while Trimethoprim functions as a dihydrofolate reductase inhibitor to provide a synergistic antibacterial effect. Each unit contains 50 capsules, ensuring a sufficient supply for standard treatment protocols.